Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Neuroimage. Clinical|January 21, 2023
Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairmentGwenn S Smith, Hillary Protas, Hiroto Kuwabara, et al.
Molecular Imaging and Biology|August 23, 2014
Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancyDean F Wong, Hiroto Kuwabara, Martin Pomper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2018
18F-XTRA PET for Enhanced Imaging of the Extrathalamic α4β2 Nicotinic Acetylcholine ReceptorJennifer M Coughlin, Stephanie Slania, Yong Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2013
PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kineticsDean F Wong, Hiroto Kuwabara, Jongho Kim, et al.
Plos One|December 11, 2014
Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in SmokersHiroto Kuwabara, Stephen J Heishman, James R Brasic, et al.
Journal of Medicinal Chemistry|August 9, 2016
Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 ReceptorRareş-Petru Moldovan, Rodrigo Teodoro, Yongjun Gao, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 16, 2024
PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagementDean F Wong, Ganesh B Chand, Nicole Caito, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2007
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PETDean F Wong, James R Brasić, Harvey S Singer, et al.
Pageof 10